CasImg
盐酸帕吉林
产品纠错
CAS号:306-07-0 | 英文名称:pargyline hydrochloride
分子式 C11H14ClN
分子量 196
EINECS号 206-175-1
MDL MFCD00012492
Smiles C1(=CC=CC=C1)CN(C)CC#C.Cl
InChIKey BCXCABRDBBWWGY-UHFFFAOYSA-N
乙二醇化学百科
基本信息
中文名称 优降宁盐酸盐
英文名称 PARGYLINE HYDROCHLORIDE
CAS号 306-07-0
分子式 C11H14ClN
分子量 195.69
EINECS号 206-175-1
物化性质
熔点 160-163 °C(lit.)
溶解度 乙醇中≥33.55 mg/mL;水中≥51.6 mg/mL; ≥7.55 mg/mL,溶于 DMSO
形态 结晶固体
颜色 从EtOH/Et2O结晶的晶体
Merck 13,7110
BRN 3699487
安全信息
危险品标志 Xn
危险类别码 22
安全说明 22-24/25
危险品运输编号 UN 2811 6.1/PG 3
WGK Germany 3
RTECS号 DP6650000
F 10
海关编码 2921199990
危险等级 6.1(b)
包装类别 III
毒性 LD50 orl-rat: 250 mg/kg 27ZQAG -,401,72
生产及用途
Pargyline hydrochloride 是一种不可逆的单胺氧化酶 (MAO) 抑制剂,对 MAO-A 和 MAO-B 的 Ki 分别为 13 μM 和 0.5 μM。Pargyline hydrochloride 具有降压和抗癌活性。
TargetValue
MAO-B
(Cell-free assay)
0.5 μM(Ki)
MAO-A
(Cell-free assay)
13 μM(Ki)

Pargyline (0.5-2 mM; 24-120 hours; LNCaP-LN3 cells) treatment inhibits the proliferation of prostate cancer cells in a time- and dose-dependent manner.
Pargyline (0.5-2 mM; 24-48 hours; LNCaP-LN3 cells) treatment decreases S phase and increases the G1 phase in the cells in a dose-dependent manner.
Pargyline (0.5 mM; 24 hours; LNCaP-LN3 cells) treatment increases the apoptotic cells.
Pargyline (2 mM; 48 hours; LNCaP-LN3 cells) treatment induces an increase of cytochrome c and a decrease of caspase-3 in the cells, but does not lead to a change of BCL-2 expression.

Cell Proliferation Assay

Cell Line: LNCaP-LN3 cells
Concentration: 0.5 mM, 1 mM, 1.5 mM or 2 mM
Incubation Time: 24 hours, 48 hours, 72 hours, 96 hours or 120 hours
Result: Inhibited the proliferation of prostate cancer cells in a time- and dose-dependent manner.

Cell Cycle Analysis

Cell Line: LNCaP-LN3 cells
Concentration: 0.5 mM, 2 mM
Incubation Time: 24 hours, 48 hours
Result: The S phase ratio of the cells was decreased, while their G1 phase ratio was increased.

Apoptosis Analysis

Cell Line: LNCaP-LN3 cells
Concentration: 0.5 mM
Incubation Time: 24 hours
Result: Increased the apoptotic cells.

Western Blot Analysis

Cell Line: LNCaP-LN3 cells
Concentration: 2 mM
Incubation Time: 48 hours
Result: Induced an increase of cytochrome c and a decrease of caspase-3.

Pargyline (10 mg/kg; iv) treatment induces a moderate (about 20 mm Hg) but persistent (48 h) decrease of systolic blood pressure in unanesthetized adult spontaneously hypertensive rats (SHR) but not in normotensive rats.
A low dose of Pargyline (200 μg; icv) injected directly into the brain lowered arterial pressure. The hypotensive action of Pargylline in SHR appears to be the consequence of Norepinephrine accumulating at an inhibitory α-adrenoceptor in brain.

用途 
具有明显的降压作用,单胺氧化酶(MAO-B)选择性抑制剂。
类别
有毒物品
毒性分级
高毒
急性毒性
口服-大鼠 LD50: 142 毫克/公斤; 口服-小鼠 LD50; 680 毫克/公斤
可燃性危险特性
可燃;燃烧产生有毒氮氧化物和氯化氢烟雾;药物副作用:影响心理状态;影响液体吸收
储运特性
通风低温干燥; 与库房食品原料分开存放
灭火剂
干粉,泡沫,沙土,二氧化碳, 雾状水
产品供应商
306-07-0
上海阿拉丁生化科技股份有限公司
2023-10-02

首页 |  CAS目录 |  产品目录 |  企业会员 |  关于我们 |  法律声明 |  注册协议

Copyright © 冀ICP备2024096099号